NCT06152471View on ClinicalTrials.gov

Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

March 31, 2025

Conditions
Early-stage Breast CancerDiarrheaAdverse Drug Event
Interventions
DRUG

SPC-flakes

Aktive drug

DRUG

Salovum

Active drug

DRUG

Placebo

Placebo drugs

Trial Locations (7)

631 88

RECRUITING

General Hospital of Eskilstuna, Eskilstuna

791 82

RECRUITING

General Hospital of Falun, Falun

801 87

NOT_YET_RECRUITING

General Hospital of Gävle, Gävle

701 85

RECRUITING

University Hospital Örebro, Örebro

856 43

NOT_YET_RECRUITING

General Hospital, Sundsvall

751 85

RECRUITING

Uppsala University Hospital, Uppsala

721 89

RECRUITING

General Hospital Västerås, Västerås

All Listed Sponsors
lead

Henrik Lindman

OTHER